Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Gross Profit: 2018-2022

Historic Gross Profit for ADC Therapeutics (ADCT) over the last 5 years, with Dec 2022 value amounting to $205,329.

  • ADC Therapeutics' Gross Profit fell 98.98% to $763,000 in Q3 2023 from the same period last year, while for Sep 2023 it was $24.1 million, marking a year-over-year decrease of 82.31%. This contributed to the annual value of $205,329 for FY2022, which is 531.32% up from last year.
  • As of FY2022, ADC Therapeutics' Gross Profit stood at $205,329, which was up 531.32% from $32,524 recorded in FY2021.
  • In the past 5 years, ADC Therapeutics' Gross Profit ranged from a high of $118.3 billion in FY2018 and a low of $814 during FY2020.
  • Moreover, its 3-year median value for Gross Profit was $32,524 (2021), whereas its average is $79,556.
  • Per our database at Business Quant, ADC Therapeutics' Gross Profit tumbled by 100.00% in 2019 and then soared by 3,895.58% in 2021.
  • Over the past 5 years, ADC Therapeutics' Gross Profit (Yearly) stood at $118.3 billion in 2018, then crashed by 100.00% to $2,340 in 2019, then plummeted by 65.21% to $814 in 2020, then soared by 3,895.58% to $32,524 in 2021, then skyrocketed by 531.32% to $205,329 in 2022.